Detalhe da pesquisa
1.
Advances in Organ Preservation for Laryngeal Cancer.
Curr Treat Options Oncol
; 23(4): 594-608, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303749
2.
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.
Oncologist
; 24(9): 1151-e817, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171735
3.
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(8): 977-1007, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390582
4.
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate.
Invest New Drugs
; 30(2): 794-802, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21174224
5.
Current controversies in the management of biochemical failure in prostate cancer.
Clin Adv Hematol Oncol
; 10(11): 716-22, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23271258
6.
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel.
Cancer Chemother Pharmacol
; 82(2): 211-219, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802443
7.
18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen.
Cancer Chemother Pharmacol
; 78(6): 1245-1252, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27817059
8.
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 77(3): 527-38, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26791870
9.
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography.
Cancer Chemother Pharmacol
; 76(1): 187-95, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26021741
10.
A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies.
Cancer Chemother Pharmacol
; 73(3): 485-93, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24414551